Financials

  • Market Capitalization 10.22 M
  • Employee 4
  • Founded 2011
  • CEO Stephen R. Brady
  • Website www.tempesttx.com
  • Headquarter Delaware, United States
  • FIGI BBG002NDK339
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4641
KPRX
Kiora Pharmaceuticals, Inc. - Common Stock
2.52 USD-1.56%+0.40%-6.67%+20.00%11.15 M USD
4648
PHIO
Phio Pharmaceuticals Corp. - Common Stock
0.93 USD+1.09%-6.06%-9.71%-21.85%10.80 M USD
4659
INTS
Intensity Therapeutics, Inc. - Common Stock
3.49 USD+5.44%-1.69%-11.87%+1063.33%11.39 M USD
4670
TOVX
Theriva Biologics, Inc. Common Stock
0.22 USD-4.35%-4.35%-8.33%-11.15%10.10 M USD

Frequently asked questions about Tempest Therapeutics, Inc. Common Stock

What is the Tempest Therapeutics, Inc. Common Stock stock price today?

The current price of Tempest Therapeutics, Inc. Common Stock (TPST) is 0.69. Over the past 24 hours, the stock has changed by -6.76%. Follow the TPST chart for real-time price dynamics.

What is the stock ticker of Tempest Therapeutics, Inc. Common Stock?

Tempest Therapeutics, Inc. Common Stock trades under the ticker TPST. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Tempest Therapeutics, Inc. Common Stock stock going up?

TPST has changed by -12.66% over the last week, -13.75% over the last month, and -71.13% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Tempest Therapeutics, Inc. Common Stock?

Tempest Therapeutics, Inc. Common Stock currently has a market capitalization of 10.22 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Tempest Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Tempest Therapeutics, Inc. Common Stock reported earnings of -0.34 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Tempest Therapeutics, Inc. Common Stock net income for the last quarter?

Tempest Therapeutics, Inc. Common Stock reported net income of -5.24 M for the last quarter. The previous quarter showed -27.7 M, which means net income changed by +81.07%.

How many employees does Tempest Therapeutics, Inc. Common Stock have?

As of the latest available data, Tempest Therapeutics, Inc. Common Stock has 4 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Tempest Therapeutics, Inc. Common Stock stock?

You can buy Tempest Therapeutics, Inc. Common Stock (TPST) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Tempest Therapeutics, Inc. Common Stock stock?

Investing in Tempest Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TPST chart and related analysis on metatrader.com as part of your research.

News